panitumumab
amgen,takeda
['panitumumab', 'crcsm', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'rectal', 'colorectal']
panitumumab plus mfolfox6 improves overall survival in a type of newly diagnosed metastatic colorectal cancer #crcsm #oncology #cancer #asco22
News and views from the world of clinical oncology and hematology